Cargando…
The Role of Thiazolidinediones in the Amelioration of Nonalcoholic Fatty Liver Disease: A Systematic Review
Non-alcoholic fatty liver disease (NAFLD) is a broad term encompassing hepatic steatosis and non-alcoholic steatohepatitis (NASH), a form of chronic hepatitis. This may, unfortunately, lead to terminal complications like cirrhosis and hepatocellular carcinoma (HCC). NAFLD is strongly associated with...
Autores principales: | Ndakotsu, Andrew, Vivekanandan, Govinathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233742/ https://www.ncbi.nlm.nih.gov/pubmed/35765391 http://dx.doi.org/10.7759/cureus.25380 |
Ejemplares similares
-
Thyroxine Replacement for Subfertile Females With Subclinical Hypothyroidism and Autoimmune Thyroiditis: A Systematic Review
por: Myneni, Revathi, et al.
Publicado: (2021) -
Clinical Management of Nonalcoholic Steatohepatitis (NASH) With the Use of Thiazolidinediones and the Additive Effect of Thiazolidinediones and a GLP-1 Agonist: Case Series
por: Rojas Ortiz, Valentina, et al.
Publicado: (2021) -
Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know
por: Bikeyeva, Viktoriya, et al.
Publicado: (2022) -
Does Type 2 Diabetes Increase the Risk of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease Patients? A Systematic Review
por: Venugopal, Sathish, et al.
Publicado: (2023) -
Prevalence of Nonalcoholic Fatty Liver Disease at a Tertiary Care Center in Saudi Arabia
por: Hussein, Ghada, et al.
Publicado: (2023)